‘Text/HTML’ of page ‘NRG-GU009: PREDICT-RT for High Risk Prostate Cancer’
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read MoreContent Block Tag: NRG-GU009: PREDICT-RT for High Risk Prostate Cancer
‘Text/HTML’ of page ‘NRG-GU009: PREDICT-RT for High Risk Prostate Cancer’
Am I eligible for this study? If you are over 18 with high-risk prostate cancer, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take this information to your doctor to discuss your questions and concerns in general […]
Read More‘Text/HTML’ of page ‘NRG-GU009: PREDICT-RT for High Risk Prostate Cancer’
About This Study NRG-GU009, also known as the “PREDICT-RT” trial, is a clinical study for people with high-risk prostate cancer that will be analyzing your prostate tumor tissue from your biopsy to test for different genes that predict the risk of your cancer spreading. This is called the Decipher risk score. If you have […]
Read More‘Text/HTML’ of page ‘NRG-GU009: PREDICT-RT for High Risk Prostate Cancer’
Clinical Studies FAQ
Read More‘Text/HTML’ of page ‘NRG-GU009: PREDICT-RT for High Risk Prostate Cancer’
PREDICT-RT STUD FAQ
Read More